London, United Kingdom · Founded 2012 · Privately Held (backing)
Operator of a biopharmaceutical company intended for developing bacterial immunotherapies for cancer. Prokarium is based in London, United Kingdom and was founded in 2012. Its last reported valuation was $109 million in Feb 2023. It has raised $88.8 million.
Last reported valuation
$109.4M
Oct 2026
Priced at
—
Total raised
$88.8M
Last round
—
Team — not yet on record
No current team members for Prokarium are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Prokarium with a free account
·The complete investor list: 12 names
·Watch Prokarium: the Monday email on marks, rounds and moves
